SEARCH RESULT

Total Matching Records found : 382

Bayer plea dismissed, Natco allowed to sell patent cancer drug

-The Business Standard Chennai: The Intellectual Property Appellate Board (IPAB) today upheld a compulsory licence issued by the Controller of Patents to Hyderabad-based Natco Pharma Ltd, a generic drug maker, to manufacture and sell a cancer drug of Bayer Corp in India. IPAB, however, made changes in the licence order by increasing the royalty payment to Bayer Corp for Nexavar, used to treat liver and kidney cancer, from six per cent to...

More »

'Breast cancer survival rates low in rural India'

-PTI Washington: Early breast cancer diagnosis and survival rates are very low among women living in rural India compared to those in developed nations, a new study has claimed. Researchers said women in developed countries survive roughly 10 years longer after a breast cancer diagnosis compared to women in poor-to-middle-income countries. The study by University of Michigan demonstrates the lack of access to good health care faced by women in poor countries, said...

More »

Pharma MNCs use RTI law to protect market for patented drugs & delay entry of generics

-The Economic Times Pharmaceutical multinationals have begun using the Right to Information law to launch pre-emptive legal action against local generic players to protect the market of patented drugs and delay the entry of low cost generic medicines in the 60,000-crore domestic drug market. MNCs are using such information to sue generic firms even at a stage when their marketing approval is still pending or during the few months' window between the...

More »

Prescribe generic drugs: MCI to doctors -Rupali Mukherjee

-The Times of India MUMBAI: The Union government and regulatory bodies appear to be serious in ending the pharma-doctor nexus and curb unethical marketing practices. In its latest effort, the Medical Council of India has directed doctors, hospitals and medical colleges to prescribe generic medicines as far as possible. generic medicines are more affordable versions of branded medicines sold by companies. In its directive dated January 21 to the principals of medical...

More »

Justice Verma panel gets tough on sexual crimes, but rejects death for rape -Manoj Mitta

-The Times of India In keeping with the public outrage over Nirbhaya's gang rape, the Justice J S Verma Committee has raised the bar of punishment for a wide range of existing and proposed sexual offences even as it rejected the demand for introducing death for rape. The report, released on Wednesday, has proposed codification of a stringent alternative to the life sentence, evolved through judicial activism in the last five years....

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close